my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Abstract:
Drug delivery to the brain is made difficult by the blood-brain barrier (BBB) which is selectively permeable to organic drug compounds. Several membrane solute and nutrient transporters are expressed in the BBB vasculature, which may be utilized as mechanism of delivery of drugs to the brain. Of interest to us, are the organic cation transporters which could be used to transport cationic compounds into the CNS. In this mini-review, we will review the current understanding of the structural requirements for designing compounds which could effectively use organic cation transporters (OCT). For the first time, structural requirements for both OCT1 and OCT2 versus the BBB choline transporter (BBBCHT) are discussed and compared. The information gained here could increase the success rate in successful CNS drug delivery and therapeutics.| Authors: | J Geldenhuys, Werner; D Allen, David | |
| Journal: | Central Nervous System Agents in Medicinal Chemistry | |
| DOI: | 10.2174/187152412800792670 |
Watchlist
This is where you can add this publication to your personal favourites.
Additional Information
Synthetic Methods for the Hydrodehalogenation of Halogenated Heterocycles
Abstract: This review provides an overview of methods that lead to the substitution of halogens from rings of halogenated heterocycles by hydrogen. The first part of the review treats the subject matter from the viewpoint of the method used for the hydrodehalogenation reaction, while ... more
Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Abstract: More needs to be done by the private sector to optimize the drug discovery and development pipeline. In addition, significant efforts should also be focused on the understanding of mechanism of diseases, on the characterization of unexplored biochemical pathways and on the ... more
New Insights in Protein Kinase Conformational Dynamics
Abstract: A significant portion of recent drug development efforts has been focused on protein kinases. More than a hundred different compounds are currently under clinical trials and nearly 30% of all the scientific articles in drug discovery are on protein kinase inhibitors. Protei ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
